Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

10x Genomics (TXG) Receivables - Net (2018 - 2026)

10x Genomics' Receivables - Net history spans 8 years, with the latest figure at $47.0 million for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 46.49% to $47.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.0 million, a 46.49% decrease, with the full-year FY2025 number at $47.0 million, down 46.49% from a year prior.
  • Receivables - Net hit $47.0 million in Q4 2025 for 10x Genomics, up from $43.8 million in the prior quarter.
  • Over the last five years, Receivables - Net for TXG hit a ceiling of $114.8 million in Q4 2023 and a floor of $43.8 million in Q3 2025.
  • Historically, Receivables - Net has averaged $77.6 million across 5 years, with a median of $81.0 million in 2021.
  • Biggest five-year swings in Receivables - Net: skyrocketed 162.61% in 2021 and later plummeted 47.59% in 2025.
  • Tracing TXG's Receivables - Net over 5 years: stood at $85.3 million in 2021, then rose by 22.24% to $104.2 million in 2022, then rose by 10.19% to $114.8 million in 2023, then fell by 23.49% to $87.9 million in 2024, then crashed by 46.49% to $47.0 million in 2025.
  • Business Quant data shows Receivables - Net for TXG at $47.0 million in Q4 2025, $43.8 million in Q3 2025, and $50.0 million in Q2 2025.